Boehringer Ingelheim's Porcine Circovirus Vaccine Approved In China, The World's Top Hog Producer
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - German drug maker Boehringer Ingelheim announced its animal health division Vetmedica has received approval from China's Ministry Of Agriculture to market its pig vaccine Ingelvac CircoFLEX for Porcine Circovirus Disease (PCVD) in China
You may also be interested in...
Pfizer Divests Its Swine Vaccine Business To Harbin Pharmaceutical Group In China As Condition Of $68 Billion Merger With Wyeth
SHANGHAI - Pfizer recently completed the divestment of its swine vaccine business in China to local company Harbin Bio-Vaccine, an animal health subsidiary of Harbin Pharmaceutical Group
Pfizer Divests Its Swine Vaccine Business To Harbin Pharmaceutical Group In China As Condition Of $68 Billion Merger With Wyeth
SHANGHAI - Pfizer recently completed the divestment of its swine vaccine business in China to local company Harbin Bio-Vaccine, an animal health subsidiary of Harbin Pharmaceutical Group
Sanofi Diversifies In China With $70 Million To Expand Production Capability For Animal Health Division Merial
SHANGHAI - Sanofi-Aventis' animal health division Merial Animal Health broke ground on a $70 million expansion of its Nanchang manufacturing site, six months after Sanofi CEO Chris Viehbacher said his company aims to diversify in China